CARPHA has announced the successful installation of Molbio rapid testing platforms across 10 Member States under the Pandemic Fund Project.
As of March 26th 2026, installations have been completed in Barbados, The Bahamas, Belize, Dominica, Grenada, Guyana, Jamaica, Saint Lucia, Turks & Caicos Islands, and Trinidad & Tobago.
These support testing for several pathogens of public health importance, including SARS-CoV-2 (COVID-19), Norovirus, Rabies, Leptospira, Salmonella, Cholera, Nipah, Influenza, Malaria, HIV, Hepatitis and Tuberculosis.
Through improved access to PCR rapid testing technologies, CARPHA and Member States are strengthening regional pandemic preparedness and response capacities.
CARPHAโs Executive Director Dr. Lisa Indar says by combining cutting-edge diagnostic technology with targeted workforce training, the organization is ensuring that countries are โbetter prepared to detect, respond to and manage public health threats in real timeโ.
